Previously we have shown that nonsyndromic cleft lip with or without cleft palate (NSCL/P)1 is strongly associated with SNPs in IRF6 (interferon regulatory factor 6)2. Here, we use multispecies sequence comparisons to identify a common SNP (rs642961, G4A) in a newly identified IRF6 enhancer. The A allele is significantly overtransmitted (P ¼ 1 1011) in families with NSCL/P, in particular those with cleft lip but not cleft palate. Further, there is a dosage effect of the A allele, with a relative risk for cleft lip of 1.68 for the AG genotype and 2.40 for the AA genotype. EMSA and ChIP assays demonstrate that the risk allele disrupts the binding site of transcription factor AP-2a and expression analysis in the mouse localizes the enhancer activity to craniofacial and limb structures. Our findings place IRF6 and AP-2a in the same developmental pathway and identify a high-frequency variant in a regulatory element contributing substantially to a common, complex disorder.

Disruption of an AP-2alpha binding site in an IRF6 enhancer is associated with cleft lip

RUBINI, Michele;
2008

Abstract

Previously we have shown that nonsyndromic cleft lip with or without cleft palate (NSCL/P)1 is strongly associated with SNPs in IRF6 (interferon regulatory factor 6)2. Here, we use multispecies sequence comparisons to identify a common SNP (rs642961, G4A) in a newly identified IRF6 enhancer. The A allele is significantly overtransmitted (P ¼ 1 1011) in families with NSCL/P, in particular those with cleft lip but not cleft palate. Further, there is a dosage effect of the A allele, with a relative risk for cleft lip of 1.68 for the AG genotype and 2.40 for the AA genotype. EMSA and ChIP assays demonstrate that the risk allele disrupts the binding site of transcription factor AP-2a and expression analysis in the mouse localizes the enhancer activity to craniofacial and limb structures. Our findings place IRF6 and AP-2a in the same developmental pathway and identify a high-frequency variant in a regulatory element contributing substantially to a common, complex disorder.
2008
Fedik, Rahimov; Mary L., Marazita; Axel, Visel; Margaret E., Cooper; Michael J., Hitchler; Rubini, Michele; Frederick E., Domann; Manika, Govil; Kaare, Christensen; Camille, Bille; Mads, Melbye; Astanand, Jugessur; Rolv T., Lie; Allen J., Wilcox; David R., Fitzpatrick; Eric D., Green; NISC Comparative Sequencing, Program; Peter A., Mossey; Julian, Little; Regine P., Steegers Theunissen; Len A., Pennacchio; Brian C., Schutte; Jeffrey C., Murray
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/533499
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 340
  • ???jsp.display-item.citation.isi??? ND
social impact